AMGN vs RMD
By Alex · Tickerpine
Amgen Inc. vs ResMed Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | AMGN | RMD |
|---|---|---|
| Price | $358.33 | $200.29 |
| Market cap | $193.39B | $29.05B |
| P/E ratio | 24.9 | 19.3 |
| ROE | 101.32% | 25.25% |
| Profit margin | 20.96% | 27.44% |
| Revenue growth | 5.80% | 10.80% |
| Dividend yield | 2.81% | 1.20% |
| Beta | 0.42 | 0.78 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
AMGN vs RMD in plain English
- AMGN is the bigger company — about 6.7× the market cap of RMD.
- RMD is cheaper on earnings (P/E 19.3 vs 24.9).
- AMGN earns a higher return on equity (101% vs 25%).
- RMD is growing revenue faster (11% vs 6%).
- AMGN has the higher dividend yield (2.81% vs 1.20%).
How would $1,000 have done in each?
AMGN return calculator
See what $1,000 in Amgen Inc. would be worth today.
RMD return calculator
See what $1,000 in ResMed Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.